Valuation: Ovation Science Inc.

Market Cap 576K 406K 355K 326K 304K 38.75M 587K 3.93M 1.52M 19M 1.53M 1.49M 65.49M P/E 2024
-2.68x
P/E 2025 -2.26x
Enterprise Value 787K 554K 485K 446K 416K 52.92M 802K 5.37M 2.08M 25.94M 2.08M 2.04M 89.45M EV / Sales 2024
13.2x
EV / Sales 2025 25.7x
Free-Float
76.54%
Yield 2024 *
-
Yield 2025 -
1 day-53.95%
3 months+65.09%
6 months+18.64%
Current year+18.64%
Current year 0.02
Extreme 0.0212
0.08
1 year 0.01
Extreme 0.0136
0.08
3 years 0
Extreme 0.0025
0.12
5 years 0
Extreme 0.0023
0.12
10 years 0
Extreme 0.0023
0.48
Manager TitleAgeSince
Director of Finance/CFO 63 2023-10-29
Chief Executive Officer 77 2017-10-03
Director TitleAgeSince
Director/Board Member 77 2017-10-03
Director/Board Member 63 2017-10-03
Director/Board Member 86 2018-02-01
Change 5-day change 1-year change 3-year change Capi.($)
-53.95%-.--% - - 406K
+2.00%+0.34%+4.05%-9.17% 231B
+0.81%-1.77%+56.10% - 51.91B
-1.47%+8.36%+160.70% - 9.85B
+3.00%+7.19%+3.91%-58.23% 6.48B
-2.96%+18.41%-39.67%-33.10% 4.68B
+5.11%+21.84%-13.16%+22.34% 4.55B
+3.22%+14.52%-11.17%-11.71% 3.7B
-2.21%+4.17%-28.40%-47.59% 3.48B
+4.17%+4.01%-21.14%-49.97% 2.47B
Average -4.23%+7.82%+12.36%-26.78% 35.37B
Weighted average by Cap. +1.68%-0.36%+15.77%-11.23%

Financials

2024 2025
Net sales 113K 79.75K 69.84K 64.15K 59.81K 7.61M 115K 772K 299K 3.73M 300K 293K 12.87M 67.89K 47.82K 41.88K 38.47K 35.87K 4.57M 69.17K 463K 179K 2.24M 180K 176K 7.72M
Net income -456K -321K -281K -258K -241K -30.68M -465K -3.11M -1.2M -15.04M -1.21M -1.18M -51.86M -631K -445K -389K -358K -334K -42.45M -643K -4.3M -1.67M -20.81M -1.67M -1.63M -71.76M
Net Debt 265K 187K 164K 150K 140K 17.83M 270K 1.81M 700K 8.74M 702K 687K 30.14M 211K 148K 130K 119K 111K 14.17M 215K 1.44M 556K 6.95M 558K 546K 23.96M
Logo Ovation Science Inc.
Ovation Science Inc. is a Canada-based drug development company. The Company develops topical and transdermal cannabidiol (CBD)/ tetrahydrocannabinol (THC) and other cannabinoid products which are out-licensed and also distributed under its own brands; ARLO CBD Beauty and InVibe MD (wellness line); all powered by its patented Invisicare skin delivery technology. The Company manufactures, distributes, sells, markets, sub-licenses and promotes products formulated with Invisicare, containing cannabinoids, hemp seed oil or synthetic derivatives of cannabis. The Company has developed topical and transdermal creams and lotions made with CBD, THC and combinations thereof plus hemp seed oil. Invisicare is a patented polymer-based technology for topical and transdermal skincare products. ARLO CBD Beauty offers science-based skincare solutions. Invibe MD offers a health and wellness product line infused with hemp-derived CBD and developed using Invisicare drug delivery technology.
Employees
-
Date Price Change Volume